NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

輸液幫浦市場預測(2021年∼2026年)

Infusion Pump Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023196
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
輸液幫浦市場預測(2021年∼2026年) Infusion Pump Market - Forecasts from 2021 to 2026
出版日期: 2021年07月08日內容資訊: 英文 111 Pages
簡介

2019年全球輸液泵市場規模達到78.71億美元。預計到 2026 年將達到 114.56 億美元,在 2019 年至 2026 年的預測期內,市場預計將以 5.51% 的複合年增長率增長。慢性病增加、醫療費用增加和醫療基礎設施改善是市場的主要增長因素。

本報告提供全球輸液幫浦市場的相關調查,提供市場動態,市場分析,競爭環境與分析,企業簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶談判力
    • 買方議價能力
    • 新加入企業的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 輸液幫浦市場分析:各類型

  • 簡介
  • 胰島素幫浦
  • PCA幫浦
  • 經腸幫浦

第6章 輸液幫浦市場分析:各機制

  • 簡介
  • 注射式幫浦
  • 彈性幫浦
  • 蠕動幫浦
  • 多頻道幫浦
  • 智慧型幫浦

第7章 輸液幫浦市場分析:各應用領域

  • 簡介
  • 化療
  • 消化器官病
  • 糖尿病
  • 疼痛管理
  • 血液
  • 其他

第8章 輸液幫浦市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東及非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第10章 企業簡介

  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Johnson & Johnson
  • Medtronic Inc.
  • Nipro Corporation
  • Option Care Health Inc.
  • Pfizer Inc.
  • Smiths Medical
  • Terumo Corporation
目錄
Product Code: KSI061610455

The global infusion pump market is evaluated at US$ 7.871 billion for the year 2019 growing at a CAGR of 5.51% reaching a market size of US$11.456 billion by the year 2026.

The infusion pump is a medical device that is used to deliver fluids into a patient's body to infuse nutrients or medications like insulin, other hormones, antibiotics, and pain relievers. Infusion pumps may be stationary or ambulatory that are designed to be portable or wearable. Different types of infusion pumps like the enteral pump, patient-controlled analgesia (PCA) pump, and insulin pump are used for specialized purposes. Depending on the mechanism used they can be classified into syringe pump, elastomeric pump, peristaltic pump, multi-channel pump, and smart pump. Geographically North America is the largest market for infusion pumps, followed by Europe, Asia-Pacific, and Latin America. The rising prevalence of chronic diseases, increasing healthcare expenditure, and improving healthcare infrastructure are major growth drivers for the market.

The global infusion pumps market is primarily driven by the rising incidence of chronic diseases, such as cancer and others, coupled with the rising adoption of these devices, owing to broadening applications of infusion pumps. Currently, infusion pumps are widely used in chemotherapy, diabetes management, and many other applications. The rising prevalence of these diseases, worldwide, is creating ample opportunities for the market to grow. For instance, according to International Diabetes Federation (IDF), in 2019, there were approximately 463 people were living with diabetes, and is estimated that the number is anticipated to grow to 700 million by 2045. In addition, technological advancements in device technology, and companies' efforts in innovating products to meet the safety and increase the adoption of devices are likely to fuel the market growth. Moreover, the market players in the global infusion pumps and accessories market are actively participating in new product launches against individual disease treatment procedures, geography expansions, and collaborations to improve their market share. One such activity includes the launch of D-mine, a wearable micro-infusion pump, used for the continuous subcutaneous administration of drugs to treat Parkinson's disease, by EVER Pharma in July 2019. Currently, there are several various types of infusion pumps available; one of them, which has gained huge popularity for continuous subcutaneous insulin infusion, is the insulin infusion pump.

The exponential rise in the number of chronic diseases and their corresponding cases has been a significant driver of the market over the years. A significant rise in the usage of insulin pumps was observed in the past decade and as per the article published by American Diabetes Association in 2018, approximately 30-40% of patients with Type 1 diabetes and a growing number of insulin-requiring patients with Type 2 diabetes are dependent on infusion pump and sensor technology. Hence, owing to all the aforementioned factors the market is anticipated to grow at high growth rates.

The market witnessed exponential growth during the year 2020 owing to the COVID-19 pandemic. In May 2020, United States Food and Drug Administration (US FDA) issued an umbrella emergency use authorization (EUA) for infusion pumps and infusion pump accessories for use by healthcare providers to treat conditions caused by the Coronavirus Disease 2019 for the controlled infusion of medications, total parenteral nutrition, and other fluid requirements. The US FDA has issued EUAs that have increased the availability of infusion pumps and infusion pump accessories, which are an integral part of the patient treatment during the COVID-19 pandemic. This guideline had a positive impact on the growth of the market in the recent past and is expected to propel at higher growth rates even in the future.

The market is expected to rise during the forecast period owing to the rising rate of obesity, growing genetic factors for type-2 diabetes, and the increasing number of type-1 diabetes patients.

Insulin pumps use is high among the type-1 diabetes population. It is also growing in type-2 patients. The ratio of children to adults, or type-1 to type-2, patient's usage of insulin pumps varies across countries. Insulin pumps reduce the large swings in blood glucose levels, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps. This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery. The insulin pump has evolved and is more reliable than it was previously. CSII technology has witnessed numerous technological advancements, like the integration of continuous glucose monitoring with the pump. Moreover, insulin pumps can control the algorithm that automatically delivers the insulin, after analyzing the blood glucose reading.

Market Segmentation

  • By Type

Insulin Pump

PCA Pump

Enteral Pump

  • By Mechanism

Syringe Pump

Elastomeric pump

Peristaltic pump

Multi-channel pump

Smart Pump

  • By Application

Chemotherapy

Gastroenterology

Diabetes

Pain management

Haematology

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Infusion Pump Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Insulin Pump
  • 5.3. PCA Pump
  • 5.4. Enteral Pump

6. Infusion Pump Market Analysis, by Mechanism

  • 6.1. Introduction
  • 6.2. Syringe Pump
  • 6.3. Elastomeric pump
  • 6.4. Peristaltic pump
  • 6.5. Multi-channel pump
  • 6.6. Smart Pump

7. Infusion Pump Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Chemotherapy
  • 7.3. Gastroenterology
  • 7.4. Diabetes
  • 7.5. Pain management
  • 7.6. Haematology
  • 7.7. Others

8. Infusion Pump Market Analysis, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. UK
    • 8.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. Baxter International Inc.
  • 10.2. Becton, Dickinson and Company
  • 10.3. Braun Melsungen AG
  • 10.4. Johnson & Johnson
  • 10.5. Medtronic Inc.
  • 10.6. Nipro Corporation
  • 10.7. Option Care Health Inc.
  • 10.8. Pfizer Inc.
  • 10.9. Smiths Medical
  • 10.10. Terumo Corporation